CN108866029B - Triterpenoids synthase TwOSC3 and its encoding gene and application - Google Patents
Triterpenoids synthase TwOSC3 and its encoding gene and application Download PDFInfo
- Publication number
- CN108866029B CN108866029B CN201810895867.6A CN201810895867A CN108866029B CN 108866029 B CN108866029 B CN 108866029B CN 201810895867 A CN201810895867 A CN 201810895867A CN 108866029 B CN108866029 B CN 108866029B
- Authority
- CN
- China
- Prior art keywords
- twosc3
- gene
- leu
- albumen
- polynucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003648 triterpenes Chemical class 0.000 title claims abstract description 45
- 108090000623 proteins and genes Proteins 0.000 title abstract description 83
- 235000015398 thunder god vine Nutrition 0.000 claims abstract description 35
- 241000830536 Tripterygium wilfordii Species 0.000 claims abstract description 28
- KQJSQWZMSAGSHN-UHFFFAOYSA-N (9beta,13alpha,14beta,20alpha)-3-hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid Natural products CC12CCC3(C)C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C2=CC=C2C1=CC(=O)C(O)=C2C KQJSQWZMSAGSHN-UHFFFAOYSA-N 0.000 claims abstract description 18
- AQKDBFWJOPNOKZ-UHFFFAOYSA-N Celastrol Natural products CC12CCC3(C)C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C2=CC=C2C1=CC(=O)C(=O)C2C AQKDBFWJOPNOKZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- KQJSQWZMSAGSHN-JJWQIEBTSA-N celastrol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)[C@](C)(C(O)=O)CC[C@]1(C)CC[C@]2(C)C4=CC=C1C3=CC(=O)C(O)=C1C KQJSQWZMSAGSHN-JJWQIEBTSA-N 0.000 claims abstract description 18
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims description 47
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 19
- 108091033319 polynucleotide Proteins 0.000 claims description 18
- 102000040430 polynucleotide Human genes 0.000 claims description 18
- 239000002157 polynucleotide Substances 0.000 claims description 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 14
- -1 triterpene compound Chemical class 0.000 claims description 13
- 239000013604 expression vector Substances 0.000 claims description 12
- 210000005253 yeast cell Anatomy 0.000 claims description 6
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 claims description 5
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 claims description 5
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 claims description 5
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 claims description 5
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 241000218636 Thuja Species 0.000 claims 1
- 238000003976 plant breeding Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 15
- 239000002299 complementary DNA Substances 0.000 abstract description 14
- 238000003786 synthesis reaction Methods 0.000 abstract description 13
- 230000014509 gene expression Effects 0.000 abstract description 11
- 150000001413 amino acids Chemical class 0.000 abstract description 10
- 239000002245 particle Substances 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 230000035772 mutation Effects 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 42
- 239000000047 product Substances 0.000 description 33
- 241000594913 Abracris flavolineata Species 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 26
- 238000000034 method Methods 0.000 description 26
- 235000018102 proteins Nutrition 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 239000002773 nucleotide Substances 0.000 description 21
- 125000003729 nucleotide group Chemical group 0.000 description 21
- 239000013612 plasmid Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
- 238000000605 extraction Methods 0.000 description 14
- 239000000499 gel Substances 0.000 description 13
- 239000001963 growth medium Substances 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000003292 glue Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 8
- 230000004087 circulation Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 241000345998 Calamus manan Species 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 235000012950 rattan cane Nutrition 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 238000011529 RT qPCR Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical class [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 4
- 101710118490 Copalyl diphosphate synthase Proteins 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 101710174833 Tuberculosinyl adenosine transferase Proteins 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- KVSNMTUIMXZPLU-XOZXFAFYSA-N friedelane Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC[C@@H]1C KVSNMTUIMXZPLU-XOZXFAFYSA-N 0.000 description 4
- 108010050848 glycylleucine Proteins 0.000 description 4
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 101710095468 Cyclase Proteins 0.000 description 3
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000235058 Komagataella pastoris Species 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- QYIMSPSDBYKPPY-UHFFFAOYSA-N OS Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC1OC1(C)C QYIMSPSDBYKPPY-UHFFFAOYSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- KPXIBWGPZSPABK-FXAWDEMLSA-N (3bR,9bS)-6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e]isobenzofuran-1-one Chemical compound C1C[C@]2(C)C3=CC=C(C(C)C)C(O)=C3CC[C@H]2C2=C1C(=O)OC2 KPXIBWGPZSPABK-FXAWDEMLSA-N 0.000 description 2
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 2
- QYIMSPSDBYKPPY-RSKUXYSASA-N (S)-2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CC[C@@H]1OC1(C)C QYIMSPSDBYKPPY-RSKUXYSASA-N 0.000 description 2
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 2
- ILQCHXURSRRIRY-YUMQZZPRSA-N Asp-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)O)N ILQCHXURSRRIRY-YUMQZZPRSA-N 0.000 description 2
- 229910000906 Bronze Inorganic materials 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 2
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 2
- YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- FRKBNXCFJBPJOL-GUBZILKMSA-N Pro-Glu-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FRKBNXCFJBPJOL-GUBZILKMSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 2
- DFBIRQPKNDILPW-CIVMWXNOSA-N Triptolide Chemical compound O=C1OCC([C@@H]2C3)=C1CC[C@]2(C)[C@]12O[C@H]1[C@@H]1O[C@]1(C(C)C)[C@@H](O)[C@]21[C@H]3O1 DFBIRQPKNDILPW-CIVMWXNOSA-N 0.000 description 2
- VIYFRTDWJXBEDM-UHFFFAOYSA-N Triptophenolide Natural products CC(C)c1ccc2c(CCC3C4=COC(=O)C4=CCC23C)c1O VIYFRTDWJXBEDM-UHFFFAOYSA-N 0.000 description 2
- OLYXUGBVBGSZDN-ACRUOGEOSA-N Tyr-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 OLYXUGBVBGSZDN-ACRUOGEOSA-N 0.000 description 2
- YTPLVNUZZOBFFC-SCZZXKLOSA-N Val-Gly-Pro Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@@H]1C(O)=O YTPLVNUZZOBFFC-SCZZXKLOSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 101150087698 alpha gene Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000012197 amplification kit Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 108010077245 asparaginyl-proline Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 239000010974 bronze Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000002247 constant time method Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000013211 curve analysis Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 108010060199 cysteinylproline Proteins 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 2
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- 230000000869 mutational effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- YKUJZZHGTWVWHA-UHFFFAOYSA-N triptolide Natural products COC12CC3OC3(C(C)C)C(O)C14OC4CC5C6=C(CCC25C)C(=O)OC6 YKUJZZHGTWVWHA-UHFFFAOYSA-N 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OQANPHBRHBJGNZ-FYJGNVAPSA-N (3e)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid Chemical compound C1=CC(=O)C(C(=O)O)=C\C1=N\NC1=CC=C(S(=O)(=O)NC=2N=CC=CC=2)C=C1 OQANPHBRHBJGNZ-FYJGNVAPSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 108050003820 2,3-oxidosqualene cyclases Proteins 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- OINNEUNVOZHBOX-QIRCYJPOSA-N 2-trans,6-trans,10-trans-geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-QIRCYJPOSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 108010036211 5-HT-moduline Proteins 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- SKHCUBQVZJHOFM-NAKRPEOUSA-N Ala-Arg-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SKHCUBQVZJHOFM-NAKRPEOUSA-N 0.000 description 1
- DECCMEWNXSNSDO-ZLUOBGJFSA-N Ala-Cys-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O DECCMEWNXSNSDO-ZLUOBGJFSA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- SIGTYDNEPYEXGK-ZANVPECISA-N Ala-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 SIGTYDNEPYEXGK-ZANVPECISA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- XSTZMVAYYCJTNR-DCAQKATOSA-N Ala-Met-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XSTZMVAYYCJTNR-DCAQKATOSA-N 0.000 description 1
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 1
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- ISCYZXFOCXWUJU-KZVJFYERSA-N Ala-Thr-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O ISCYZXFOCXWUJU-KZVJFYERSA-N 0.000 description 1
- YCTIYBUTCKNOTI-UWJYBYFXSA-N Ala-Tyr-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCTIYBUTCKNOTI-UWJYBYFXSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- IASNWHAGGYTEKX-IUCAKERBSA-N Arg-Arg-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O IASNWHAGGYTEKX-IUCAKERBSA-N 0.000 description 1
- DCGLNNVKIZXQOJ-FXQIFTODSA-N Arg-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N DCGLNNVKIZXQOJ-FXQIFTODSA-N 0.000 description 1
- USNSOPDIZILSJP-FXQIFTODSA-N Arg-Asn-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O USNSOPDIZILSJP-FXQIFTODSA-N 0.000 description 1
- BJNUAWGXPSHQMJ-DCAQKATOSA-N Arg-Gln-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O BJNUAWGXPSHQMJ-DCAQKATOSA-N 0.000 description 1
- UAOSDDXCTBIPCA-QXEWZRGKSA-N Arg-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UAOSDDXCTBIPCA-QXEWZRGKSA-N 0.000 description 1
- OOIMKQRCPJBGPD-XUXIUFHCSA-N Arg-Ile-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O OOIMKQRCPJBGPD-XUXIUFHCSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- BNYNOWJESJJIOI-XUXIUFHCSA-N Arg-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N BNYNOWJESJJIOI-XUXIUFHCSA-N 0.000 description 1
- BTJVOUQWFXABOI-IHRRRGAJSA-N Arg-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N BTJVOUQWFXABOI-IHRRRGAJSA-N 0.000 description 1
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 1
- DDBMKOCQWNFDBH-RHYQMDGZSA-N Arg-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O DDBMKOCQWNFDBH-RHYQMDGZSA-N 0.000 description 1
- OGZBJJLRKQZRHL-KJEVXHAQSA-N Arg-Thr-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OGZBJJLRKQZRHL-KJEVXHAQSA-N 0.000 description 1
- PYDIIVKGTBRIEL-SZMVWBNQSA-N Arg-Trp-Pro Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(O)=O PYDIIVKGTBRIEL-SZMVWBNQSA-N 0.000 description 1
- CGWVCWFQGXOUSJ-ULQDDVLXSA-N Arg-Tyr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O CGWVCWFQGXOUSJ-ULQDDVLXSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- HZPSDHRYYIORKR-WHFBIAKZSA-N Asn-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O HZPSDHRYYIORKR-WHFBIAKZSA-N 0.000 description 1
- LXTGAOAXPSJWOU-DCAQKATOSA-N Asn-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)N)N LXTGAOAXPSJWOU-DCAQKATOSA-N 0.000 description 1
- JEPNYDRDYNSFIU-QXEWZRGKSA-N Asn-Arg-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(O)=O JEPNYDRDYNSFIU-QXEWZRGKSA-N 0.000 description 1
- DMLSCRJBWUEALP-LAEOZQHASA-N Asn-Glu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O DMLSCRJBWUEALP-LAEOZQHASA-N 0.000 description 1
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 1
- PBSQFBAJKPLRJY-BYULHYEWSA-N Asn-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N PBSQFBAJKPLRJY-BYULHYEWSA-N 0.000 description 1
- SPCONPVIDFMDJI-QSFUFRPTSA-N Asn-Ile-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O SPCONPVIDFMDJI-QSFUFRPTSA-N 0.000 description 1
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 1
- MVXJBVVLACEGCG-PCBIJLKTSA-N Asn-Phe-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVXJBVVLACEGCG-PCBIJLKTSA-N 0.000 description 1
- HZZIFFOVHLWGCS-KKUMJFAQSA-N Asn-Phe-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O HZZIFFOVHLWGCS-KKUMJFAQSA-N 0.000 description 1
- KSZHWTRZPOTIGY-AVGNSLFASA-N Asn-Tyr-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O KSZHWTRZPOTIGY-AVGNSLFASA-N 0.000 description 1
- DZQKLNLLWFQONU-LKXGYXEUSA-N Asp-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N)O DZQKLNLLWFQONU-LKXGYXEUSA-N 0.000 description 1
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- RQYMKRMRZWJGHC-BQBZGAKWSA-N Asp-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)N RQYMKRMRZWJGHC-BQBZGAKWSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 1
- MYOHQBFRJQFIDZ-KKUMJFAQSA-N Asp-Leu-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYOHQBFRJQFIDZ-KKUMJFAQSA-N 0.000 description 1
- GWIJZUVQVDJHDI-AVGNSLFASA-N Asp-Phe-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GWIJZUVQVDJHDI-AVGNSLFASA-N 0.000 description 1
- GPPIDDWYKJPRES-YDHLFZDLSA-N Asp-Phe-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GPPIDDWYKJPRES-YDHLFZDLSA-N 0.000 description 1
- BWJZSLQJNBSUPM-FXQIFTODSA-N Asp-Pro-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O BWJZSLQJNBSUPM-FXQIFTODSA-N 0.000 description 1
- HJZLUGQGJWXJCJ-CIUDSAMLSA-N Asp-Pro-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJZLUGQGJWXJCJ-CIUDSAMLSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- GHAHOJDCBRXAKC-IHPCNDPISA-N Asp-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N GHAHOJDCBRXAKC-IHPCNDPISA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- ZWIADYZPOWUWEW-XVFCMESISA-N CDP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-XVFCMESISA-N 0.000 description 1
- 101100520513 Caenorhabditis elegans wee-1.3 gene Proteins 0.000 description 1
- 241000222128 Candida maltosa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000251556 Chordata Species 0.000 description 1
- SURTWIXUHQNUGN-GUBZILKMSA-N Cys-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N SURTWIXUHQNUGN-GUBZILKMSA-N 0.000 description 1
- BUUVFIAZIOIEIN-UBHSHLNASA-N Cys-Cys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)N BUUVFIAZIOIEIN-UBHSHLNASA-N 0.000 description 1
- SFRQEQGPRTVDPO-NRPADANISA-N Cys-Gln-Val Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O SFRQEQGPRTVDPO-NRPADANISA-N 0.000 description 1
- WVLZTXGTNGHPBO-SRVKXCTJSA-N Cys-Leu-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O WVLZTXGTNGHPBO-SRVKXCTJSA-N 0.000 description 1
- JXVFJOMFOLFPMP-KKUMJFAQSA-N Cys-Leu-Tyr Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JXVFJOMFOLFPMP-KKUMJFAQSA-N 0.000 description 1
- HSAWNMMTZCLTPY-DCAQKATOSA-N Cys-Met-Leu Chemical compound SC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O HSAWNMMTZCLTPY-DCAQKATOSA-N 0.000 description 1
- MFMDKTLJCUBQIC-MXAVVETBSA-N Cys-Phe-Ile Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MFMDKTLJCUBQIC-MXAVVETBSA-N 0.000 description 1
- ALNKNYKSZPSLBD-ZDLURKLDSA-N Cys-Thr-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ALNKNYKSZPSLBD-ZDLURKLDSA-N 0.000 description 1
- VIOQRFNAZDMVLO-NRPADANISA-N Cys-Val-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VIOQRFNAZDMVLO-NRPADANISA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- VWFJDQUYCIWHTN-FBXUGWQNSA-N Farnesyl diphosphate Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/COP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-FBXUGWQNSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 1
- XFKUFUJECJUQTQ-CIUDSAMLSA-N Gln-Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XFKUFUJECJUQTQ-CIUDSAMLSA-N 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 1
- UTOQQOMEJDPDMX-ACZMJKKPSA-N Gln-Ser-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O UTOQQOMEJDPDMX-ACZMJKKPSA-N 0.000 description 1
- SAHTWBLTLJWAQA-XIRDDKMYSA-N Gln-Trp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)N)N SAHTWBLTLJWAQA-XIRDDKMYSA-N 0.000 description 1
- JTWZNMUVQWWGOX-SOUVJXGZSA-N Gln-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)N)N)C(=O)O JTWZNMUVQWWGOX-SOUVJXGZSA-N 0.000 description 1
- HNAUFGBKJLTWQE-IFFSRLJSSA-N Gln-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N)O HNAUFGBKJLTWQE-IFFSRLJSSA-N 0.000 description 1
- NKSGKPWXSWBRRX-ACZMJKKPSA-N Glu-Asn-Cys Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N NKSGKPWXSWBRRX-ACZMJKKPSA-N 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- WATXSTJXNBOHKD-LAEOZQHASA-N Glu-Asp-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O WATXSTJXNBOHKD-LAEOZQHASA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- CAVMESABQIKFKT-IUCAKERBSA-N Glu-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N CAVMESABQIKFKT-IUCAKERBSA-N 0.000 description 1
- NJPQBTJSYCKCNS-HVTMNAMFSA-N Glu-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N NJPQBTJSYCKCNS-HVTMNAMFSA-N 0.000 description 1
- NWOUBJNMZDDGDT-AVGNSLFASA-N Glu-Leu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NWOUBJNMZDDGDT-AVGNSLFASA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- YUXIEONARHPUTK-JBACZVJFSA-N Glu-Phe-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)[C@H](CCC(=O)O)N YUXIEONARHPUTK-JBACZVJFSA-N 0.000 description 1
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 description 1
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 1
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 1
- RQZGFWKQLPJOEQ-YUMQZZPRSA-N Gly-Arg-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)CN)CN=C(N)N RQZGFWKQLPJOEQ-YUMQZZPRSA-N 0.000 description 1
- DJTXYXZNNDDEOU-WHFBIAKZSA-N Gly-Asn-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN)C(=O)N DJTXYXZNNDDEOU-WHFBIAKZSA-N 0.000 description 1
- YDWZGVCXMVLDQH-WHFBIAKZSA-N Gly-Cys-Asn Chemical compound NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC(N)=O YDWZGVCXMVLDQH-WHFBIAKZSA-N 0.000 description 1
- CUYLIWAAAYJKJH-RYUDHWBXSA-N Gly-Glu-Tyr Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CUYLIWAAAYJKJH-RYUDHWBXSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- SIYTVHWNKGIGMD-HOTGVXAUSA-N Gly-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)CN SIYTVHWNKGIGMD-HOTGVXAUSA-N 0.000 description 1
- FCKPEGOCSVZPNC-WHOFXGATSA-N Gly-Ile-Phe Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FCKPEGOCSVZPNC-WHOFXGATSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- PYFIQROSWQERAS-LBPRGKRZSA-N Gly-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(=O)NCC(O)=O)=CNC2=C1 PYFIQROSWQERAS-LBPRGKRZSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 244000286779 Hansenula anomala Species 0.000 description 1
- 235000014683 Hansenula anomala Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- JHVCZQFWRLHUQR-DCAQKATOSA-N His-Arg-Cys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N JHVCZQFWRLHUQR-DCAQKATOSA-N 0.000 description 1
- VYMGAXSNYUFVCK-GUBZILKMSA-N His-Gln-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N VYMGAXSNYUFVCK-GUBZILKMSA-N 0.000 description 1
- ORERHHPZDDEMSC-VGDYDELISA-N His-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N ORERHHPZDDEMSC-VGDYDELISA-N 0.000 description 1
- JENKOCSDMSVWPY-SRVKXCTJSA-N His-Leu-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O JENKOCSDMSVWPY-SRVKXCTJSA-N 0.000 description 1
- ZHMZWSFQRUGLEC-JYJNAYRXSA-N His-Tyr-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZHMZWSFQRUGLEC-JYJNAYRXSA-N 0.000 description 1
- DPTBVFUDCPINIP-JURCDPSOSA-N Ile-Ala-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DPTBVFUDCPINIP-JURCDPSOSA-N 0.000 description 1
- FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 1
- MVLDERGQICFFLL-ZQINRCPSSA-N Ile-Gln-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 MVLDERGQICFFLL-ZQINRCPSSA-N 0.000 description 1
- IXEFKXAGHRQFAF-HVTMNAMFSA-N Ile-Glu-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N IXEFKXAGHRQFAF-HVTMNAMFSA-N 0.000 description 1
- KOPIAUWNLKKELG-SIGLWIIPSA-N Ile-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N KOPIAUWNLKKELG-SIGLWIIPSA-N 0.000 description 1
- TWPSALMCEHCIOY-YTFOTSKYSA-N Ile-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O)N TWPSALMCEHCIOY-YTFOTSKYSA-N 0.000 description 1
- AXNGDPAKKCEKGY-QPHKQPEJSA-N Ile-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N AXNGDPAKKCEKGY-QPHKQPEJSA-N 0.000 description 1
- GAZGFPOZOLEYAJ-YTFOTSKYSA-N Ile-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N GAZGFPOZOLEYAJ-YTFOTSKYSA-N 0.000 description 1
- PMMMQRVUMVURGJ-XUXIUFHCSA-N Ile-Leu-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O PMMMQRVUMVURGJ-XUXIUFHCSA-N 0.000 description 1
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 1
- SAVXZJYTTQQQDD-QEWYBTABSA-N Ile-Phe-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SAVXZJYTTQQQDD-QEWYBTABSA-N 0.000 description 1
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 1
- HJDZMPFEXINXLO-QPHKQPEJSA-N Ile-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N HJDZMPFEXINXLO-QPHKQPEJSA-N 0.000 description 1
- KBDIBHQICWDGDL-PPCPHDFISA-N Ile-Thr-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N KBDIBHQICWDGDL-PPCPHDFISA-N 0.000 description 1
- ANTFEOSJMAUGIB-KNZXXDILSA-N Ile-Thr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N ANTFEOSJMAUGIB-KNZXXDILSA-N 0.000 description 1
- RWHRUZORDWZESH-ZQINRCPSSA-N Ile-Trp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RWHRUZORDWZESH-ZQINRCPSSA-N 0.000 description 1
- FXJLRZFMKGHYJP-CFMVVWHZSA-N Ile-Tyr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FXJLRZFMKGHYJP-CFMVVWHZSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- GRZSCTXVCDUIPO-SRVKXCTJSA-N Leu-Arg-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O GRZSCTXVCDUIPO-SRVKXCTJSA-N 0.000 description 1
- VKOAHIRLIUESLU-ULQDDVLXSA-N Leu-Arg-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VKOAHIRLIUESLU-ULQDDVLXSA-N 0.000 description 1
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 1
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- FOBUGKUBUJOWAD-IHPCNDPISA-N Leu-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FOBUGKUBUJOWAD-IHPCNDPISA-N 0.000 description 1
- UCNNZELZXFXXJQ-BZSNNMDCSA-N Leu-Leu-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCNNZELZXFXXJQ-BZSNNMDCSA-N 0.000 description 1
- DCGXHWINSHEPIR-SRVKXCTJSA-N Leu-Lys-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)N DCGXHWINSHEPIR-SRVKXCTJSA-N 0.000 description 1
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 1
- VQHUBNVKFFLWRP-ULQDDVLXSA-N Leu-Tyr-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 VQHUBNVKFFLWRP-ULQDDVLXSA-N 0.000 description 1
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 1
- WALVCOOOKULCQM-ULQDDVLXSA-N Lys-Arg-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WALVCOOOKULCQM-ULQDDVLXSA-N 0.000 description 1
- YVSHZSUKQHNDHD-KKUMJFAQSA-N Lys-Asn-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N YVSHZSUKQHNDHD-KKUMJFAQSA-N 0.000 description 1
- HEWWNLVEWBJBKA-WDCWCFNPSA-N Lys-Gln-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN HEWWNLVEWBJBKA-WDCWCFNPSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 1
- XIZQPFCRXLUNMK-BZSNNMDCSA-N Lys-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N XIZQPFCRXLUNMK-BZSNNMDCSA-N 0.000 description 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 1
- SKUOQDYMJFUMOE-ULQDDVLXSA-N Lys-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N SKUOQDYMJFUMOE-ULQDDVLXSA-N 0.000 description 1
- SEZADXQOJJTXPG-VFAJRCTISA-N Lys-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N)O SEZADXQOJJTXPG-VFAJRCTISA-N 0.000 description 1
- ZJSXCIMWLPSTMG-HSCHXYMDSA-N Lys-Trp-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZJSXCIMWLPSTMG-HSCHXYMDSA-N 0.000 description 1
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 1
- BXNZDLVLGYYFIB-FXQIFTODSA-N Met-Asn-Cys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N BXNZDLVLGYYFIB-FXQIFTODSA-N 0.000 description 1
- JYCQGAGDJQYEDB-GUBZILKMSA-N Met-Gln-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O JYCQGAGDJQYEDB-GUBZILKMSA-N 0.000 description 1
- GPAHWYRSHCKICP-GUBZILKMSA-N Met-Glu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GPAHWYRSHCKICP-GUBZILKMSA-N 0.000 description 1
- QZPXMHVKPHJNTR-DCAQKATOSA-N Met-Leu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O QZPXMHVKPHJNTR-DCAQKATOSA-N 0.000 description 1
- JYPITOUIQVSCKM-IHRRRGAJSA-N Met-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCSC)N JYPITOUIQVSCKM-IHRRRGAJSA-N 0.000 description 1
- MIAZEQZXAFTCCG-UBHSHLNASA-N Met-Phe-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 MIAZEQZXAFTCCG-UBHSHLNASA-N 0.000 description 1
- YDKYJRZWRJTILC-WDSOQIARSA-N Met-Trp-Lys Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 YDKYJRZWRJTILC-WDSOQIARSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001452677 Ogataea methanolica Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- VLZGUAUYZGQKPM-DRZSPHRISA-N Phe-Gln-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VLZGUAUYZGQKPM-DRZSPHRISA-N 0.000 description 1
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 1
- KDYPMIZMXDECSU-JYJNAYRXSA-N Phe-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KDYPMIZMXDECSU-JYJNAYRXSA-N 0.000 description 1
- FZBGMXYQPACKNC-HJWJTTGWSA-N Phe-Pro-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FZBGMXYQPACKNC-HJWJTTGWSA-N 0.000 description 1
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 1
- IPFXYNKCXYGSSV-KKUMJFAQSA-N Phe-Ser-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N IPFXYNKCXYGSSV-KKUMJFAQSA-N 0.000 description 1
- XNMYNGDKJNOKHH-BZSNNMDCSA-N Phe-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XNMYNGDKJNOKHH-BZSNNMDCSA-N 0.000 description 1
- XNQMZHLAYFWSGJ-HTUGSXCWSA-N Phe-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XNQMZHLAYFWSGJ-HTUGSXCWSA-N 0.000 description 1
- RGMLUHANLDVMPB-ULQDDVLXSA-N Phe-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGMLUHANLDVMPB-ULQDDVLXSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 1
- FYQSMXKJYTZYRP-DCAQKATOSA-N Pro-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FYQSMXKJYTZYRP-DCAQKATOSA-N 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- DEDANIDYQAPTFI-IHRRRGAJSA-N Pro-Asp-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DEDANIDYQAPTFI-IHRRRGAJSA-N 0.000 description 1
- WSRWHZRUOCACLJ-UWVGGRQHSA-N Pro-Gly-His Chemical compound C([C@@H](C(=O)O)NC(=O)CNC(=O)[C@H]1NCCC1)C1=CN=CN1 WSRWHZRUOCACLJ-UWVGGRQHSA-N 0.000 description 1
- FJLODLCIOJUDRG-PYJNHQTQSA-N Pro-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H]2CCCN2 FJLODLCIOJUDRG-PYJNHQTQSA-N 0.000 description 1
- RYJRPPUATSKNAY-STECZYCISA-N Pro-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@@H]2CCCN2 RYJRPPUATSKNAY-STECZYCISA-N 0.000 description 1
- FYPGHGXAOZTOBO-IHRRRGAJSA-N Pro-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H]2CCCN2 FYPGHGXAOZTOBO-IHRRRGAJSA-N 0.000 description 1
- XYSXOCIWCPFOCG-IHRRRGAJSA-N Pro-Leu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XYSXOCIWCPFOCG-IHRRRGAJSA-N 0.000 description 1
- XZBYTHCRAVAXQQ-DCAQKATOSA-N Pro-Met-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O XZBYTHCRAVAXQQ-DCAQKATOSA-N 0.000 description 1
- ANESFYPBAJPYNJ-SDDRHHMPSA-N Pro-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ANESFYPBAJPYNJ-SDDRHHMPSA-N 0.000 description 1
- WLJYLAQSUSIQNH-GUBZILKMSA-N Pro-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H]1CCCN1 WLJYLAQSUSIQNH-GUBZILKMSA-N 0.000 description 1
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 1
- VEUACYMXJKXALX-IHRRRGAJSA-N Pro-Tyr-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VEUACYMXJKXALX-IHRRRGAJSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- WXUBSIDKNMFAGS-IHRRRGAJSA-N Ser-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WXUBSIDKNMFAGS-IHRRRGAJSA-N 0.000 description 1
- VAIZFHMTBFYJIA-ACZMJKKPSA-N Ser-Asp-Gln Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(N)=O VAIZFHMTBFYJIA-ACZMJKKPSA-N 0.000 description 1
- OJPHFSOMBZKQKQ-GUBZILKMSA-N Ser-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO OJPHFSOMBZKQKQ-GUBZILKMSA-N 0.000 description 1
- UICKAKRRRBTILH-GUBZILKMSA-N Ser-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N UICKAKRRRBTILH-GUBZILKMSA-N 0.000 description 1
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- HEYZPTCCEIWHRO-IHRRRGAJSA-N Ser-Met-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HEYZPTCCEIWHRO-IHRRRGAJSA-N 0.000 description 1
- XKFJENWJGHMDLI-QWRGUYRKSA-N Ser-Phe-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O XKFJENWJGHMDLI-QWRGUYRKSA-N 0.000 description 1
- UPLYXVPQLJVWMM-KKUMJFAQSA-N Ser-Phe-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UPLYXVPQLJVWMM-KKUMJFAQSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
- BCAVNDNYOGTQMQ-AAEUAGOBSA-N Ser-Trp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(O)=O BCAVNDNYOGTQMQ-AAEUAGOBSA-N 0.000 description 1
- PCMZJFMUYWIERL-ZKWXMUAHSA-N Ser-Val-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMZJFMUYWIERL-ZKWXMUAHSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- NFMPFBCXABPALN-OWLDWWDNSA-N Thr-Ala-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O NFMPFBCXABPALN-OWLDWWDNSA-N 0.000 description 1
- DIPIPFHFLPTCLK-LOKLDPHHSA-N Thr-Gln-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O DIPIPFHFLPTCLK-LOKLDPHHSA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 1
- 241000545405 Tripterygium Species 0.000 description 1
- NMCBVGFGWSIGSB-NUTKFTJISA-N Trp-Ala-Leu Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N NMCBVGFGWSIGSB-NUTKFTJISA-N 0.000 description 1
- PXQPYPMSLBQHJJ-WFBYXXMGSA-N Trp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N PXQPYPMSLBQHJJ-WFBYXXMGSA-N 0.000 description 1
- LHHDBONOFZDWMW-AAEUAGOBSA-N Trp-Asp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LHHDBONOFZDWMW-AAEUAGOBSA-N 0.000 description 1
- HXMJXDNSFVNSEH-IHPCNDPISA-N Trp-Cys-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N HXMJXDNSFVNSEH-IHPCNDPISA-N 0.000 description 1
- DZIKVMCFXIIETR-JSGCOSHPSA-N Trp-Gly-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O DZIKVMCFXIIETR-JSGCOSHPSA-N 0.000 description 1
- DNUJCLUFRGGSDJ-YLVFBTJISA-N Trp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C21)N DNUJCLUFRGGSDJ-YLVFBTJISA-N 0.000 description 1
- YXSSXUIBUJGHJY-SFJXLCSZSA-N Trp-Thr-Phe Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)[C@H](O)C)C(O)=O)C1=CC=CC=C1 YXSSXUIBUJGHJY-SFJXLCSZSA-N 0.000 description 1
- UGFOSENEZHEQKX-PJODQICGSA-N Trp-Val-Ala Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(O)=O UGFOSENEZHEQKX-PJODQICGSA-N 0.000 description 1
- HKYTWJOWZTWBQB-AVGNSLFASA-N Tyr-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HKYTWJOWZTWBQB-AVGNSLFASA-N 0.000 description 1
- CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 1
- GFJXBLSZOFWHAW-JYJNAYRXSA-N Tyr-His-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GFJXBLSZOFWHAW-JYJNAYRXSA-N 0.000 description 1
- SBLZVFCEOCWRLS-BPNCWPANSA-N Tyr-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=C(C=C1)O)N SBLZVFCEOCWRLS-BPNCWPANSA-N 0.000 description 1
- PSALWJCUIAQKFW-ACRUOGEOSA-N Tyr-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N PSALWJCUIAQKFW-ACRUOGEOSA-N 0.000 description 1
- QHONGSVIVOFKAC-ULQDDVLXSA-N Tyr-Pro-His Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O QHONGSVIVOFKAC-ULQDDVLXSA-N 0.000 description 1
- LUMQYLVYUIRHHU-YJRXYDGGSA-N Tyr-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUMQYLVYUIRHHU-YJRXYDGGSA-N 0.000 description 1
- AOIZTZRWMSPPAY-KAOXEZKKSA-N Tyr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O AOIZTZRWMSPPAY-KAOXEZKKSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 1
- WBUOKGBHGDPYMH-GUBZILKMSA-N Val-Cys-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)C(C)C WBUOKGBHGDPYMH-GUBZILKMSA-N 0.000 description 1
- BRPKEERLGYNCNC-NHCYSSNCSA-N Val-Glu-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N BRPKEERLGYNCNC-NHCYSSNCSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 1
- ZZGPVSZDZQRJQY-ULQDDVLXSA-N Val-Leu-Phe Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O ZZGPVSZDZQRJQY-ULQDDVLXSA-N 0.000 description 1
- MHHAWNPHDLCPLF-ULQDDVLXSA-N Val-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 MHHAWNPHDLCPLF-ULQDDVLXSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- PDASTHRLDFOZMG-JYJNAYRXSA-N Val-Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 PDASTHRLDFOZMG-JYJNAYRXSA-N 0.000 description 1
- VVIZITNVZUAEMI-DLOVCJGASA-N Val-Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O VVIZITNVZUAEMI-DLOVCJGASA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010084217 alanyl-glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010078114 alanyl-tryptophyl-alanine Proteins 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 108010004073 cysteinylcysteine Proteins 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000012510 peptide mapping method Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- RXHIKAIVEMAPRU-JRIGQVHBSA-N sequiterpene Natural products C1=C(C)[C@@H](OC(C)=O)[C@H](O)[C@@]2(O)[C@H](C)CC[C@@H](C(C)=C)[C@H]21 RXHIKAIVEMAPRU-JRIGQVHBSA-N 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 108010087432 terpene synthase Proteins 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- 229940094989 trimethylsilane Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- 108010084932 tryptophyl-proline Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/99—Intramolecular transferases (5.4) transferring other groups (5.4.99)
- C12Y504/99007—Lanosterol synthase (5.4.99.7), i.e. oxidosqualene-lanosterol cyclase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The present invention relates to a kind of triterpenoids synthase TwOSC3 albumen and its encoding genes, by the cDNA clone of Twosc3 gene to carrier for expression of eukaryon pYES2, building has the recombinant expression carrier of Twosc3 gene, is transferred to Yeast expression host strain, can produce to obtain suberone.By mutation research, the result shows that, the amino acid 482 of Twosc3 gene coding is critical sites, can be improved or reduce the yield of suberone or armomadendrin.Shown by the interference experiment that particle gun mediates, the interference of Twosc3 gene has apparent inhibiting effect for the synthesis of Celastrol in tripterygium wilfordii, TwOSC3 albumen and its encoding gene of the present invention can be used for biosynthesis plant triterpene class compound, and cultivate the tripterygium wilfordii of high-quality.
Description
Technical field
The present invention relates to a kind of triterpenoids synthase and its encoding genes and three diterpene synthase and its encoding gene to exist
Utilization in triterpene compound biosynthesis belongs to Gene Engineering of Medicinal Plants field.
Background technique
Chinese herb triperygium wilfordii derives from the drying of medicinal plant tripterygium wilfordii (Tripterygium wilfordii.Hook.f.)
The xylem of root, be widely used in rheumatoid arthritis and inflammation treatment (Raphaela G M, Mildred W, Roy F,
et al.Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the
Treatment of Rheumatoid Arthritis:A Randomized Trial[J].Annals of Internal
Medicine,2009,151(4):229-240.Tao X L,Lipsky P E.The Chinese anti-inflammatory
and immunosuppressive herbal remedy Tripterygium wilfordii Hook F.[J]
.Rheumatic Disease Clinics of North America,2000,26(1):29–50.).Ter penoids are Thunder God
The main active of rattan, including triptolide (triptolide), triptophenolide (triptophenolide) and tripterygium wilfordii
Red pigment (celastrol) etc..It is a kind of very promising mode from the active constituent developing new drug in Chinese medicine, however due to plant
Slow growth, along with content of these effective components in plant is few, thus greatly limit its development.Pass through
Biosynthesis pathway and its regulatory mechanism of the ter penoids in tripterygium wilfordii are sought and illustrated, the formation for medical material quanlity is facilitated
It provides fundamental basis, while to be brought using biotechnology raising target component content or direct production effective component or intermediate
Wide application space.
There is anti-inflammatory, antirheumatic using the Celastrol of friedelane type as the triterpene compound of representative in tripterygium wilfordii, resist
Tumour, weight-reducing, immunosupress, treatment neurogenic disease isoreactivity (Liu J, Lee J, Salazarhernandez M A, et
al.Treatment of Obesity with Celastrol[J].Cell,2015,161(5):999–1011.).Pass through born of the same parents
The 2-methyl-D-erythritol-4- of mevalonate pathway (mevalonic acid (MVA) pathway) and plastid of slurry
Universal substrate isopentenylpyrophosphate (the Isopentenyl pyrophosphate of phosphate (MEP) approach generation terpene
And its isomers Dimethylallyl pyrophosphate (DMAPP) (IPP)).Thus generate monoterpene respectively again
(monoterpenes), sequiterpene (sesquiterpenes), the bottom of diterpene (diterpenes) and triterpene (triterpenes)
Object geranyl pyrophosphate (Geranyl diphosphate (GPP)), farnesyl pyrophosphate (farnesyl diphosphate
And Mang ox base Mang ox base pyrophosphoric acid (geranylgeranyl diphosphate (GGPP)) (FPP)).
Three diterpene synthases (Triterpene synthase), also known as triterpene cyclase (Triterpene cyclase) or 2,
3- squalene oxide cyclase (2,3-oxidosqualene cyclase, OSC), it is considered to be synthesis triterpenes secondary metabolism is whole
The key enzyme of product, it can be catalyzed 2,3- oxidosqualene and form triterpene skeleton.The present invention is cloned from thunder god vine suspending cell
A Twosc3 gene is obtained, by verifying its biological function that there is catalysis 2.3- oxidosqualene to generate suberone, and it is wooden
Bolt ketone is the mother nucleus structure of cork alkane type triterpenoid (Celastrol, flat modeling rattan element etc.), and suberone is by modification enzyme such as P450 etc.
The triterpene compound that Celastrol etc. has significant pharmacological activity can be generated in the modification of gene.The gene is for the first time from thunder
The key gene of the synthesis of triterpenes components obtained in public rattan, before the present invention comes forth, there has been no any disclosure or reports
Triterpenoids synthase gene and its amino acid sequence mentioned in present patent application are crossed in road.
Summary of the invention
The present invention provides a kind of isolated albumen, the albumen participates in the biosynthesis of triterpene compound, especially
The biosynthesis of friedelane type triterpene compound.
In the present invention, the isolated albumen is a kind of synthesis for participating in triterpenoids class compound, especially Thunder God
The key enzyme of rattan red pigment synthesis, is named as triterpenoids synthase (Tripterygium wilfordii herein
Triterpene synthase, TwOSC3), the triterpenoids synthase includes
(1) amino acid sequence shown in SEQ ID NO:2;Or
(2) amino acid sequence shown in SEQ ID NO:2 is substituted, lacks or increases one or more amino acid and function
Identical peptide.
In the present invention, TwOSC3 albumen or polypeptide refer to: there are three terpene synthase activities (to participate in friedelane type triterpenes
Close object biosynthesis) SEQ ID NO:2 sequence polypeptide, certainly further include have and natural TwOSC3 identical function
The variant form of SEQ ID NO:2 sequence.These variant forms include but is not limited to: several (usually 1-50, preferably
Ground 1-30, more preferably 1-20, most preferably 1-10) missing, insertion and/or the substitution of amino acid, and C-terminal and/
Or one or several (usually 20 within, be more preferably within 5 within the preferably 10) amino acid of N-terminal addition.
For example, in the art, when being substituted with similar nature or similar amino acid, not usually changing the function of albumen.Again
For example, the function of protein will not be changed by adding one or several amino acid generally also in C-terminal and/or N-terminal.TwOSC3 egg
White or polypeptide further includes the active fragment and reactive derivative of TwOSC3, further includes that can be operatively connected to signal peptide, open
The derivative of mover, ribosome bind site or terminator sequence composition.
TwOSC3 protein variant or polypeptide with substantial similar sequence identity be characterized by having one or
Multiple amino acid substitutions, missing or insertion.These changes are preferably smaller in nature, i.e., conserved amino acid substitution (being shown in Table 1) and
The folding or active other substitutions of polypeptide are not significantly affected;Small missing, the missing of typically one to about 30 amino acid;
Amino or c-terminus extend, such as aminoterminal methionine residues, the small joint peptide or affine of no more than about 20-25 residue
Label.Present invention accordingly provides comprising with SEQ ID NO:2 at least 70%, preferably at least have 90%, be more preferable 95%,
96%, the polypeptide of 97%, 98%, 99% or more consistent sequence.
1 conserved amino acid of table substitution
It can determine comprising for maintaining the region of structural intergrity key or the amino acid residue in domain.It can determine at this
More or less tolerance changes and keeps the specific residue of the entire tertiary structure of molecule in a little regions.The method of analytical sequence structure
Include, but are not limited to the comparison with multiple sequences of homoamino acid or nucleotide identity, secondary structure tendency
(propensity), second level member figure (binary patterns), complementary accumulation are (complementary packing) and hidden
Polar interaction (Barton, Current Opin.Struct.Biol.5:372-376,1995;With Cordes etc.,
Current Opin.Struct.Biol.6:3-10,1996).Generally, when designing molecular modification or identification specific fragment,
By the activity of the molecule of evaluation modification while determining structure.
Amino acid sequence can be carried out in TwOSC3 albumen to change at least to destroy to the necessary height of biological activity
Level structure.For example, amino acid residue will be changed when TwOSC3 albumen includes one or more spirals so as not to destroy spiral
It is other that geometry and conformational change therein will be such that some key functions (such as combination of molecule partner in connection) weakens
Molecular chaperones.The effect that amino acid sequence changes can be predicted for example, by computer simulation disclosed above, or be passed through
Crystal structure analysis is measured (see such as Lapthorn etc., Nat.Struct.Biol.2:266-268,1995).This field
Well known other technologies are compared the folding for changing albumen and standard molecule (such as native protein), for example, can compare
Cysteine distribution situation in variant and standard molecule.Mass spectrum and using reduction and alkylated chemical modification be measurement and two
Sulfide linkage is relevant or the cysteine residues of not formed these keys provide method (Bean etc., Anal.Biochem.201:216-
266,1992;Gray, Protein Sci.2:1732-1748,1993;With Patterson etc., Anal.Chem.66:3727-
3732,1994).If being generally acknowledged that the molecule of modification and standard molecule have different cysteine distribution situation, roll over
It is folded to be affected.Another received well-known process for being used to measure this point is C. D. spectrum (CD).Measure and compare modification
The CD spectrum that molecule and standard molecule generate is conventional (Johnson, Proteins 7:205-214,1990).Crystallography is another
One analysis fold and structure well-known process, nuclear magnetic resonance (NMR), digestion peptide mapping and epitope mapping be also analysis fold and
The known method (Schaanan etc., Science 257:961-964,1992) of structural similarity between proteins and peptides.
In the present invention, the variant forms of triterpenoids synthase protein include: homologous sequence, conservative variant, etc.
Position variant, induced mutants, can hybridize under high or low high stringency conditions natural mutation with triterpenoids synthase gene
The encoded albumen of DNA.
Preferably, the isolated protein variant is by one or more in amino acid sequence shown in SEQ ID NO:2
A amino acid is mutated as follows:
482nd Leu is sported into Ile, Ser, Val, Phe, Pro, Arg or Ala.
Still a further object of the present invention provides a kind of polynucleotide sequence for encoding the triterpenoids synthase protein.
The polynucleotide sequence is a kind of gene related with triterpenoids class compound synthesis: i.e. tripterygium wilfordii
Triterpene synthase gene (Twosc3 gene), it is one of following nucleotide sequences:
1) SEQ ID No.1 115-2406 nucleotide sequences in sequence table;Or
2) there are one or several bases with the nucleotide sequence of SEQ ID No.1 115-2406 locator qualification in sequence table
Mutation, and encode the DNA sequence dna of identical function protein;Or
3) nucleotides sequence under high stringency conditions with nucleotide sequence hybridization shown in SEQ ID NO:1 115-2406
Column, the stringent condition are as follows: hybridize in 0.1 × SSPE containing 0.1%SDS or 0.1 × SSC solution containing 0.1% SDS,
And film is washed with the solution.
Wherein the nucleotide sequence " TAG " of 2404-2406 is terminator codon.
Triterpenoids synthasee code gene of the present invention refers to: encoding the nucleosides with triterpenoids synthase protein
Acid sequence, such as 115-2406 nucleotide sequences and its degenerate sequence in SEQ ID NO:1.The degenerate sequence refers to positioned at SEQ
In 115-2406 nucleotide of encoder block of ID NO:1 sequence, there are one or more codons to be encoded same amino acid
The sequence generated after replaced degenerate codon.Due to the degeneracy of codon, so with 115- in SEQ ID NO:1
2406 nucleotide sequence homologies can also encode out sequence described in SEQ ID NO:2 down to about 70% degenerate sequence.Also
Including can under moderate stringency conditions, more preferably under high stringent condition in SEQ ID NO:1 from nucleotide 115-2406
The nucleotide sequence of the nucleotide sequence hybridization of position.Further include and the core in SEQ ID NO:1 from 115-2406, nucleotide
The homology of nucleotide sequence at least 70%, preferably at least 80%, more preferably at least 90%, most preferably at least 95% nucleotide
Sequence.It further include that can encode to have to open with the SEQ ID NO:1 of the albumen of natural triterpenoids synthase identical function
The variant form of reading frame sequence.These variant forms include but is not limited to several (usually 1-90, preferably 1-60
A, more preferably 1-20, most preferably 1-10) nucleotide missing, insertion and/or substitution, and in 5 ' and/or 3 ' end additions
Several (usually 60 within, within preferably 30, be more preferably within 10, be most preferably within 5) nucleotide.
" rigor " of hybridization reaction can determine readily by those of ordinary skill in the art, and generally according to probe
Length, wash temperature and salinity calculate by rule of thumb.In general, the longer higher temperature of probes call to be correctly to anneal, and compared with
Short probe needs lower temperature.Hybridization is often relied on when complementary strand is present in time-varying in the environment lower than its melting temperature
The ability that property DNA anneals again.Probe and can expectation degree of homology between hybridization sequences it is higher, workable relative temperature
Also higher.As a result, being inferred to higher relative temperature would tend to keep reaction condition more stringent, and lower temperature is also just less
Strictly.About the other details of hybridization reaction rigor and explanation, referring to Ausubel et al., " Current Protocols in
Molecular Biology ", Wiley Interscience Publishers, 1995.
" high stringency conditions " or " high high stringency conditions " can identify as follows as defined herein: (1) strong using low ion
Degree and high temperature are washed, such as 0.015M sodium chloride/0.0015M sodium citrate/0.1% lauryl sodium sulfate, and 50 DEG C;
(2) denaturant is used in hybrid process, such as formamide, such as 50% (v/v) formamide and 0.1% bovine serum albumin/
0.1%Ficoll/0.1% polyvinylpyrrolidone/50mM sodium phosphate buffer pH 6.5, sodium chloride containing 750mM, 75mM lemon
Sour sodium, 42 DEG C;Or (3) are using 50% formamide, 5x SSC (0.75M NaCl, 0.075M sodium citrate), 50mM sodium phosphate
(pH 6.8), 0.1% sodium pyrophosphate, 5x DenhardtShi solution, the salmon sperm dna (50 μ g/ml) of ultrasonication, 0.1%
In 42 DEG C of hybridized overnights in the solution of SDS and 10% dextran glucosides, and in 42 DEG C in 0.2x SSC (sodium chloride/lemon
Sour sodium) middle washing 10 minutes, high stringency washing in 10 minutes is then carried out in 55 DEG C in the 0.1x SSC containing EDTA.
A further purpose of the present invention is to provide a kind of expression vector, the expression vector includes to encode thunder of the present invention
The polynucleotides of public rattan triterpene synthase protein or its variant, or the nucleotide that can hybridize with the polynucleotides under high stringency conditions
Sequence, the expression vector also includes promoter and terminator, wherein the promoter operationally connects with the polynucleotides
It connects, and the polynucleotides are operably connected with the transcription terminator.
In the present invention, various carriers known in the art can be selected, such as commercially available carrier, including plasmid, clay etc..In life
When producing triterpenoids synthase polypeptide of the present invention, the nucleotide sequence of triterpenoids synthase gene can be operably connected
In expression regulation sequence, to form triterpenoids synthase expression vectors." the operationally downlink connection " is when finger DNA section
When indicate these sections according to certain way arrangement so that they can play a role in phase for purpose expected from it, such as
Starting, which is transcribed and moved ahead, in promoter reaches terminator by coding section.Also refer to such a situation: i.e. linear DNA molecule
Certain parts can influence same linear DNA molecule other parts activity, for example, if signal peptide DNA is expressed simultaneously as premise
The secretion of polypeptide is participated in, then signal peptide (secretion leader sequence) DNA is exactly to be operably connected to be connected to polypeptid DNA;If opened
Mover control sequence transcription, then it is to be operably connected to coded sequence;If ribosome bind site, which is placed in, to be made
When its position translated, then it is to be operably coupled to coded sequence.Generally, " being operably connected ", it is adjacent to mean, and
Secretion leader sequence is then meaned adjacent in reading frame.
It is a further object of the present invention to provide a kind of host cell, the host cell includes coding of the present invention
The polynucleotide molecule of TwOSC3 albumen or its variant, or can be hybridized with the polynucleotide molecule under high stringency conditions
Nucleic acid molecule, or the expression vector comprising foregoing description of the present invention.The host cell is selected from: bacterium, prokaryotic cell are (such as
Escherichia coli) fungal cell, yeast cells, insect cell, mammalian cell or plant cell, it is preferable that it is yeast cells
Or plant cell.
Especially interesting yeast includes saccharomyces cerevisiae, pichia pastoris yeast and Pichia methanolica.With outer
Source DNA transformed saccharomyces cerevisiae cell and such as Kawassaki, United States Patent (USP) are disclosed in from the method for wherein preparation and reorganization polypeptide
In US4599311, US4931373, US4870008, US5037743, US4845075 etc..Pass through table determined by selected marker
Type, usually drug resistance or the growth ability when lacking specific nutrient (such as leucine) select transformed cells.For making
The preferred vector system of brewer yeast such as can be pYES2 expression vector.Appropriate promoters and terminator for yeast include coming
From those of glycolytic gene (US4599311, US4615974 and US4977092) and alcohol dehydrogenase.For other yeast, packet
Include multiform Hansenula anomala, newborn Kluyveromyces yeasts, Kluyveromyces fragilis, pichia pastoris yeast, Pichia
The conversion system of Methanolica, Guilliermondii Pichia pastoris and Candida maltosa are also known in the art.
According to conventional methods in the culture medium containing nutrient and other necessary ingredients of growth for selected host cell
Middle culture conversion or transfection host cell.A variety of suitable culture mediums, including known culture medium and complicated culture medium,
Be it is known in the art, generally comprise carbon source, nitrogen source, essential amino acid, vitamin and mineral.If desired, culture medium is also
Ingredient as such as growth factor or serum can be contained.Growth medium is generally for example, by drug screening or lack can be by
Required nutrient that expression vector carries or selected marker that cotransfection is into host cell supplement is selected containing external source addition
The cell of DNA.By conventional methods, small triangular flask or fermentor jet are such as shaken, sufficient air is provided to liquid culture.
Triterpenoids synthase polynucleotides full length sequence of the invention or its segment usually can with PCR amplification method, again
Group method or artificial synthesized method obtain.For PCR amplification method, can disclosed related nucleotide sequence according to the present invention, especially
It is that open reading frame sequence carrys out design primer, and with the commercially available library cDNA or presses conventional method well known by persons skilled in the art
The library cDNA is prepared as template, expands and obtains related sequence.When sequence is longer, it is often necessary to which PCR expands twice or repeatedly for progress
Increase, then the segment that each time amplifies is stitched together by proper order again.Once obtaining related sequence, so that it may use
Recombination method obtains related sequence in large quantity.This is usually to be cloned into carrier, then be transferred to cell, then passes through routine side
Method isolated related sequence from the host cell after proliferation.In addition, also mutant can be introduced this hair by chemical synthesis
In bright protein sequence.Other than being generated with recombination method, solid phase technique is also can be used in the segment of albumen of the present invention, by directly synthesizing
Peptide and produced (Stewart etc., Solid-Phase Pedtide Synthesis, J.Am.Chem.Soc.85:2149-
2154,1963).Synthetic proteins matter can carry out by hand or automatically in vitro.For example, Applied Biosystems can be used
431A type peptide synthesizer (Foster City, CA) be automatically synthesized peptide.Each of chemical synthesis albumen of the present invention can be distinguished
Section, is then chemically connected to generate the molecule of overall length.
In the present invention, term " triterpenoids synthase gene " or " Twosc3 gene " are used interchangeably;Term " tripterygium wilfordii
Three diterpene synthases ", " three diterpene synthases ", " triterpenoids synthase protein ", " TwOSC3 " or " TwOSC3 albumen " are used interchangeably.Art
Language " nucleic acid molecule " or " nucleotide sequence " are used interchangeably.
Term " separation " or " purifying ", polypeptide or protein refers under conditions of its non-natural surroundings, such as from
It opens blood or organizes existing polypeptide or protein.In a preferred form, more peptide or proteins of separation are essentially free of other
Other more peptide or proteins of more peptide or proteins, especially animal origin or plant origin.Preferably provide high purity form, i.e., it is pure
Degree is greater than the polypeptide that 95%, more preferable purity is greater than 99%;" separation " or " purifying " DNA refers to, the DNA or segment from
Separated in the sequence of its two sides under native state, or refer to the DNA or segment under native state with nucleic acid
Component separate, and separated with cell with its protein.
Triterpenoids synthase protein and triterpenoids synthase gene provided by the invention are for the first time from tripterygium wilfordii gram
Grand preparation, directly participate in the biosynthesis of triterpene compound, typically compound such as suberone.Since suberone is wood
The front body structure of bolt alkane type triterpenoid class compound (Celastrol), therefore can be improved in plant by technique for gene engineering
The content of Celastrol in the content or friedelane type triterpene compound of suberone such as tripterygium wilfordii plant, particle gun are situated between
The Twosc3 gene interference led the results show that triterpenoids synthase gene conjunction of the interference for Celastrol in tripterygium wilfordii
At there is apparent inhibiting effect, the suspension cell comparison for being transferred to the interference carrier of the gene containing Twosc3 is transferred to unloaded suspension cell
Twosc3 gene expression amount is remarkably decreased (interference), and corresponding trypterygine cellulose content is remarkably decreased (interference), prompts its right
Celastrol synthesis plays a significant role.Twosc3 gene can be used for improving trypterygine cellulose content using transgenic technology
Research and industrialization in, be used especially for the quality-improving of Chinese herb triperygium wilfordii, for alleviate tripterygium wilfordii medicine source scarcity problem have
Preferable facilitation can be used for tripterygium wilfordii breeding.
In one embodiment of the invention, triterpenoids synthase or triterpenoids synthase of the present invention are provided
Utilization of the gene in synthesis triterpene compound, the triterpene compound, such as can be suberone, Celastrol.
In one embodiment of the invention, provide a kind of by using triterpenoids synthase of the present invention or thunder
Public rattan triterpene synthase gene adjusts and the method for production plant triterpene class compound, the triterpene compound such as suberone or thunder
Celastrol.It include: (1) thunder god vine suspending with the method that TwOSC3 albumen or Twosc3 gene obtain plant triterpene constituents
The culture of cell;(2) thunder god vine suspending cell RNA is extracted;(3) thunder god vine suspending cell transcript profile is sequenced;(4) Twosc3 gene
Full-length cDNA obtains;(5) plasmid and strain construction;(6) recombinant;(7) engineering bacterium expression product is extracted and is separated.
Detailed description of the invention
The tissue expression of Fig. 1 Twosc3 gene (three biology of each sample repeat, and three technologies repeat)
Fig. 2 Twosc3 gene tunning GC-MS result figure (standard items peak 1 is cupreol, and 2 be beta-amyrin, 3
It is suberone for lupeol, 4)
482 mutation result product GC-MS detection figures of Fig. 3 TwOSC3 albumen (1 is beta-amyrin, and 2 be suberone)
The product assay measurement result of Fig. 4 Twosc3 and its mutant
(CK is to be transferred to unloaded suspension to the content of the interference of Fig. 5 thunder god vine suspending cell Twosc3 gene and Celastrol
Cell, Ri are to be transferred to the thunder god vine suspending cell with Twosc3 gene interference carrier)
Specific embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
The materials, reagents and the like used in the following examples is commercially available unless otherwise specified.
Quantitative test in following embodiments, is respectively provided with three repeated experiments, and results are averaged.
Tripterygium wilfordii (Tripterygium wilfordii Hook.f.) suspension cell in following embodiments is in document " thunder
The full-length clone and expression analysis Chinese medicine of public rattan 4- (5 '-cytidine diphosphate (CDP)) -2-C- methyl D-erythrite kinase gene
Magazine, 2015,40 (21): being disclosed in 4165-4170 ", and the public can be real from Capital University of Medical Sciences's molecule crude drug and natural resources of Chinese medicinal materials
Test room acquisition.
PEASY-Blunt Simple Cloning Kit and Fast Mutagenesis System in following embodiments
It is the product of Beijing Quanshijin Biotechnology Co., Ltd;
Phusion High-Fidelity PCR Master Mix with HF Buffer and various endonucleases are equal
Purchased from New England Biolabs company;
SMARTerTM RACE cDNA Amplification Kit is the product of Takara company;
FastQuant RT Kit kit, the small extraction reagent kit of rapid plasmid are purchased from Tiangeng biochemical technology Co., Ltd.
Beta-amyrin (β-Amyrin) is Mei Lun biotech firm product, and batch number M0505AS, No. CAS is 559-70-
6;
Suberone (Friedelin) is the product of Mei Lun biotech firm, and batch number M0308AS, No. CAS is 559-
74-0;
Lupeol (Lupeol) is Aladdin (aladding) Products, batch number #JI409077, article No.
L114079-10mg, No. CAS is 545-47-1;
Cupreol (β-sitosterol) is Aladdin (aladding) Products, batch number #D1605025,
Article No. S111183-20mg, No. CAS is 83-46-5.
The clone of embodiment 1, tripterygium wilfordii Twosc3 full length cDNA sequence
1. the acquisition of the first chain of thunder god vine suspending cell Total RNAs extraction and cDNA
Using modified CTAB method (CTAB Buffer:2%CTAB (W/V);100mmol·L-1Tris-HCl(pH 8.0);
25mmol·L-1EDTA;2.0mol·L-1NaCl;0.5g·L-1Spermidine) extract thunder god vine suspending cell total serum IgE.To obtain
The total serum IgE obtained is template, utilizes 5 '-CDS in SMARTerTM RACE cDNA Amplification Kit kit
Primer carries out reverse transcription respectively and obtains 5 '-RACE-Ready cDNA.
2. design of primers
Screen to obtain full length gene sequence fragment according to tripterygium wilfordii transcript profile data notes, design Twosc3-F and
Twosc3-R primer, primer sequence are as follows:
Twosc3-F:AAACACAAGAGATTGATATAAGC (SEQ ID NO:3)
Twosc3-R:TTCGATTTAGCGGACACT (SEQ ID NO:4)
3.PCR amplification
The 5 '-RACE-Ready cDNA obtained using step 1 are carried out as template using Twosc3-F and Twosc3-R primer
PCR amplification obtains pcr amplification product.
PCR response procedures: 98 DEG C of initial denaturation 30s;98 DEG C of 10s, 60 DEG C of 15s, 72 DEG C of 2min, 35 circulations;72 DEG C of extensions
5min。
Amplified production recycles (method is as follows) through Gene JET Gel Extraction Kit glue.
Gene JET Gel Extraction Kit glue recycling step:
(1) 6 × loading buffer of PCR product and 9 μ L is taken to be pre-mixed, with low electricity on 1.5% Ago-Gel
Press (about 5Vcm-1) electrophoresis 30-60min;
(2) cut the gel containing DNA fragmentation with scalpel or slasher, film is placed on the 1.5mL that weighs in advance from
Heart pipe is simultaneously weighed.The weight of recording film.
(3) plus the Binding Buffer of 1:1 amount (is measured by weight, such as every 100 milligrams of Ago-Gels add into film
100 microlitres of Binding Buffer);
(4) gel mixture 10min is incubated under conditions of 50-60 DEG C, is during which mixed by inversion 2-3 times, and glue is promoted to melt,
Guarantee that glue all dissolves, gel mixture is quickly vortexed mixing once before upper prop;
(5) most 800 μ L gel lysates are shifted to gene recovery purifying column, 13000g is centrifuged 1min, discards efflux,
Then column is put back into identical collecting pipe;
(6) 700 μ LWash Buffer (being diluted with ethyl alcohol) are added and arrive Gene JET purification column.13000g is centrifuged 1min,
Efflux is discarded, column is then put back into identical collecting pipe;
(7) centrifugation sky GeneJET purification column 13000g is centrifuged 1min, completely removes remaining Wash Buffer;
(8) Gene JET purification column is transferred to a clean 1.5mL centrifuge tube, adds 30-50 μ L ddH2O (can be 60 DEG C
Preheating) in purification column film, 13000g is centrifuged 1min;
(9) it loses Gene JET purification column and stores the DNA of purifying at -20 DEG C.
3. carrier connects
The recovery product of 4 μ L is taken, the B-Zero being added in 1 μ LpEASY-Blunt Simple Cloning Kit reagent is pre-
Mixed liquid after mixing, 25 DEG C in PCR instrument, connects 15min.
4. connection product converts
(1) above-mentioned connection product is all added in the Trans1-T1 competent cell of 50 μ L, 30min is placed in ice;
After (2) 42 DEG C of heat shock 1min, then place 2min in ice;
(3) addition 1mLLB culture medium, 37 DEG C, 180rpm shaken cultivation 1h;
(4) it draws 200 μ L bacterium solutions to be coated on LB+Amp solid medium, 37 DEG C of culture 14h observe bacterium colony growing state.
5, bacterium solution PCR verifies positive bacterium colony
In super-clean bench, with the single bacterium colony in the sterilized white pipette tips picking plate of 10 μ L, it is placed in LB+Amp culture medium
In, 37 DEG C, after 250rpm constant-temperature shaking culture about 1-2h, 1 μ L bacterium solution is taken to carry out bacterium solution PCR, testing goal segment whether with load
On body effectively connects.
PCR reaction system:
PCR reaction condition:
PCR product is observed in gel imager after the detection of 1% agarose gel electrophoresis.2200bp or so to occur
The bacterium solution of target fragment band send sequencing company to be sequenced;
Sequencing result shows: the sequence of pcr amplification product is as shown in sequence 1, by unnamed gene shown in sequence 1
Twosc3, wherein 115-2406 are open reading frame (ORF) from 5 ' end, encode the egg being made of 763 amino acid residues
White matter (wherein the nucleotide sequence " TAG " of 2404-2406 is terminator codon), which is named as TwOSC3, the albumen
Amino acid sequence is sequence 2.
Embodiment 2, Twosc3 gene organization expression analysis
1. the processing of experimental material
Tripterygium root, stem, leaf, flower are picked up from five different plants of Yongan City, Fujian Province state-owned forest farms.It is clear that sample fetches laboratory
It washes, minus 80 refrigerator is stored in after liquid nitrogen flash freezer.
2. extraction and the Real-time quantitative PCR of total serum IgE
The root for being stored in minus 80 refrigerator, stem, leaf, flower are crushed under liquid nitrogen environment, total serum IgE is extracted with modified CTAB method, uses
FastQuant RT Kit kit (Tiangeng) reverse transcription is at cDNA, using tripterygium wilfordii EF1 α gene as internal reference.Using ABI
Prism 7300Sequence Detection System (Applied Biosystems, USA) and KAPA SYBR FAST
Universal 2X qPCR Master Mix (Kapa Biosystems, USA) kit carries out Real-time quantitative PCR.
Real time fluorescent quantitative reaction system: 2 × Fast qPCR Master Mix 10uL, positive anti-primer (10mmolL-1) are each
0.4uL, cDNA1uL, 50 × Rox High 0.4uL, PCR-grade water 7.8uL.Reaction condition are as follows: 95 DEG C of 3min, 95
DEG C 3s, 60 DEG C of 30s, 45 circulations: 65~95 DEG C are done solubility curve analysis.After reaction to fluorescent value amplification curve and melting
Curve is analyzed.Biology repeats 3, and technology is repeated 3 times, using 2-△△CT method analyzes result.Primer sequence is as follows:
Twosc3-F:5 '-AGTATCCTGATGGCTCGTGG-3 ' (SEQ ID NO:5)
Twosc3-R:5 '-CCCATCCACCATCATCACTC-3 ' (SEQ ID NO:6)
EF1 α-F:5 '-CCAAGGGTGAAAGCAAGGAGAGC-3 ' (SEQ ID NO:7)
EF1 α-R:5 '-CACTGGTGGTTTTGAGGCTGGTATCT-3 ' (SEQ ID NO:8)
As a result as shown in Figure 1.After the homogenization of EF1 α reference gene, Twosc3 gene relative expression levels are highest be
In root, followed by stem, followed by flower, Twosc3 gene relative expression quantity are minimum in leaf.Prompt Twosc3 is mainly responsible in root
The synthesis of suberone, this is consistent with the main Germ distribution of Celastrol.
Embodiment 3, the research of tripterygium wilfordii Twosc3 biological function
1. construction of eukaryotic expression vector
Using the carrier pEASY-Blunt-Twosc3 plasmid containing tripterygium wilfordii Twosc3 full length gene cDNA as template, with containing
Restriction enzyme site primer (mark horizontal line is restriction enzyme site), carries out PCR amplification gene coding region.Archaeal dna polymerase uses high-fidelity DNA
Polymerase (Phusion High-Fidelity PCR Master Mix).PCR parameter is 98 DEG C of 30s, 1 circulation;98 DEG C of 10s,
60 DEG C of 10s, 72 DEG C of 2min 30s, 35 circulations;72℃5min;4 DEG C of maintenances.Amplified production is through Gene JET Gel
Extraction Kit glue recycles (method is as follows).
Twosc3-F:CGGGGTACCATGTGGAAGATAAAGATAGCTGA (SEQ ID NO:9)
Twosc3-R:CGCGGATCCCTATTTAATTTCCTTTGAAGGC (SEQ ID NO:10)
Gene JET Gel Extraction Kit glue recycling step (with glue recycling step in embodiment 1):
PCR product after recovered carries out double digestion with restriction enzyme, is oriented using 4 DNA ligase of NEB company's T
It is connected into (method is as follows) in the expression vector pYES2 through identical double digestion.
Double enzyme digestion reaction system (50 μ L system)
Agarose gel electrophoresis after 37 DEG C of reaction 2h, Gene JET Gel Extraction Kit glue recycle target fragment
Method is same as above.
Connection reaction (20 μ L system)
* DNA and carrier molar ratio are about 3:1-10:1
25 DEG C of connection 1h, connection product is inverted, (specific steps in embodiment 1 the same as connecting for positive colony preliminary screening
Practice midwifery the conversion and single colonie bacterium solution PCR verifying of object), sample presentation sequencing identification obtains being sequenced nucleotide sequence and recombinates without mutation
Plasmid pYES2-Twosc3.
2. yeast ferments
The preparation of competent yeast
By at ATCC buy lactosterol synthase defect yeast (4021900TM) draw and containing Geneticin
On the YPD solid medium of 0.2mg/mL, 30 DEG C dark culture two days.Picking single colonie 30 DEG C in 20mL YPD culture medium,
250rpm is cultivated to OD600 up to 0.8-1.0, is prepared using Frozen-EZ Yeast Transformation IITM kit
After competent yeast cells, the expression vector pYES2-Twosc3 of building is converted.Specific step is as follows:
(1) bacterium solution is centrifuged 4min in refrigerated centrifuge 500g, abandons supernatant.
(2) 10mL EZ 1solution washing thalline is added, 500g is centrifuged 4min, abandons supernatant.
(3) 1mL EZ 2solution is added and thallus is resuspended, every 50uL bacterium solution is dispensed into 1.5mL EP pipe, gradient cooling
After be stored in minus 80 DEG C of refrigerators or be directly used in carrier conversion.
(4) it takes the plasmid (less than 5uL) of 0.2-1ug that 50uL competent yeast cells are added, adds 500uL EZ
3solution is mixed completely.
(5) 30 DEG C of incubation 45min.Period is flicked or mediation 2-3 times with finger.
(6) 50uL-150uL Incubating Solution is taken to be coated on Sc-ura yeast screening assay culture medium, 30 DEG C of dark culture 2d.
Fermentation process
For the saccharomycete of zero load conversion as control, picking single bacterium falls within 30 DEG C of 5mL Sc-ura fluid nutrient medium, 250rpm
Overnight incubation is verified for bacterium solution PCR.Bacterium containing purpose band is saved as into glycerol stock, and takes 20uL bacterium solution new in 20mL
30 DEG C of Sc-ura fluid nutrient medium, 250rpm cultivates 2d, be changed to Sc-ura induced medium (containing galactolipin), 30 DEG C,
220rpm Fiber differentiation 12h, then with 30 DEG C of the 0.1M potassium phosphate of 20mL (containing glucose, PH7.0), 220rpm cultivates 1d.
3. product GC-MS is detected
Bacterium solution centrifugation after fermentation, takes thallus that 10mL 20%KOH/50%EtOH solution ultrasonic extraction 10min is added, uses
Three times, after extract liquor merges, nitrogen is blown flings to solvent to 10mL n-hexane extraction, and 100uL anhydrous pyridine and 100uL trifluoroacetyl is added
65 DEG C of derivatization 60min of amine (containing trimethyl silane).Nitrogen is blown volatilize solvent after, 800uL chloroform redissolve, filter membrane, GC-MS inspection
It surveys.GC-MS condition: sample volume 1uL, 50 DEG C of holdings 1min, 50 DEG C of min-1Rise to 260 DEG C;1℃·min-1272 DEG C are risen to,
Keep 4min.250 DEG C of injector temperature, 230 DEG C of ion source temperature, electron energy 70ev, 10-550m/z range is carried out to sample
Scanning.GC-MS instrument is Agilent Technologies company Agilent 7890B gas chromatograph, chromatography
Column is DB-5ms (15m × 250um × 0.1um).
As a result see Fig. 2.Compared with being transferred to unloaded control group yeast extract, it is transferred to the yeast extract of Twosc3 gene
In detect suberone, illustrate the albumen of Twosc3 gene expression can be catalyzed 2,3- oxidosqualene formed suberone.
4. rite-directed mutagenesis
In addition to mutational site, two primer lengths about 25-30bp, 5 ' end overlay regions include 15-20bp, 3 ' end extension areas
Include at least 10bp;Mutational site is located on two primers, is located at forward mutation assay primer overlay region downstream, close to overlapping
Area, rite-directed mutagenesis primer is designed according to the above principle in the end of inverse transition primer 5 ', ' DCTAE ' functional domain upstream second
Twosc3CTT (L) is mutated into GTT (V) by (482) at amino acid, ATT (I), TCT (S), TTT (F), GCT (A), CCT (P)
With CGT (R).Rite-directed mutagenesis primer sequence:
Reaction system
After above-mentioned system mixes, in PCR instrument, initial denaturation 94 DEG C of 5min, 94 DEG C of 20s, 55 DEG C of 20s, 72 DEG C of 3min 30s,
25 circulations, 72 DEG C of extension 10min.1uL DMT enzymic digestion product, 37 DEG C of reaction 1h are added after reaction.4uL digestion is taken to produce
50uL DMT competent cell is added in object, mixes, ice bath 30min, 42 DEG C of water-bath 45s, ice bath 2min, and the LB training of 500uL is added
Base is supported, 200rpm, 37 DEG C of culture 1h are coated on 37 DEG C of cultures on LB+AMP culture dish.Positive colony is sent be sequenced successfully after, extract
Plasmid.
The mutant plasmid of extraction is transferred in competent yeast cells (in example 3 prepared by step 2), is trained in Sc-ura yeast
Base culture is supported, subsequent picking single colonie is fermented and induced, and extracts product, (step is the same as embodiment 3 for GC-MS testing result
In 2 and 3).
As a result as shown in Figure 3.The 482nd leucine (L) is mutated into respectively on the amino acid sequence of Twosc3 coding
Product disappears afterwards for alanine (A), phenylalanine (F), arginine (R) and proline (P), illustrates the loss of activity of enzyme;And 482
Position is mutated into valine (V), serine (S) respectively, and product becomes 2 (beta-amyrins) afterwards, and product 4 (suberone) disappears, wherein will
After the 482nd leucine (L) is mutated into isoleucine (I) on the amino acid sequence of Twosc3 coding, while generating 2 He of product
Product 4, and the content of product 4 is promoted.Further there are the mutant strain of variation and Twosc3 wild product assay
Type bacterial strain carries out fermenting respectively quantitatively, and fermentation step and product extract detection method and be same as above.Three repetitions of each bacterial strain, product
Measurement result is shown in Fig. 4.
Embodiment 4, tripterygium wilfordii Twosc3 gene interfere the influence synthesized to Celastrol
1. thunder god vine suspending cell prepares
Prepare MS solid medium: Murashige&Skoog with Vitamins (Caisson Labs company)
4.43g/L, sucrose (AOBOX company) 30g/L, 2,4-D 1.0mg/L, KT 0.1mg/L adjust PH to 5.8-6.0 after adding water, add
Agarose (Oxoid company) 6-8g, pours into 35mm cell culture when temperature drops to 60 DEG C or less after 20min high pressure sterilization by 121 DEG C
Solidification in ware (each culture dish 3ml culture medium).
Will the suspension cell of subculture be transferred in the 35mm Tissue Culture Dish that culture medium is added that (each culture dish 0.2g suspends
Cell), 25 DEG C, dark culture 6-9d is used for via Particle Bombardment Transformation.
2.gateway technology constructs Twosc3 interference carrier
The building of BP entry vector
Design primer is as follows:
Interfere primer Twosc3-F:CACCGCACTGCTGAAGCATTAAAGT (SEQ ID NO:25)
Twosc3-R:CATACCACGAGCCATCAGG (SEQ ID NO:26)
Using the carrier pEASY-Blunt-Twosc3 plasmid containing tripterygium wilfordii Twosc3 full length gene cDNA as template, with containing
Restriction enzyme site primer (mark horizontal line is restriction enzyme site), carries out PCR amplification gene coding region.Archaeal dna polymerase uses high-fidelity DNA
Polymerase (Phusion High-Fidelity PCR Master Mix).PCR parameter is 98 DEG C of 30s, 1 circulation;98 DEG C of 10s,
60 DEG C of 10s, 72 DEG C of 2min 30s, 35 circulations;72℃5min;4 DEG C of maintenances.Amplified production is through Gene JET Gel
The recycling of Extraction Kit glue.
BP reaction system
Competent escherichia coli cell Trans1-T1 (Beijing Quan Shi King Company) is transferred to after 22 DEG C of reaction 2h to train in LB+Kan
Support the culture of 37 DEG C of base, positive colony is sent be sequenced successfully after, the small extraction reagent kit extraction plasmid of rapid plasmid.
LR reaction system
* pK7 is interference carrier
25 DEG C of reaction 3-4h, are added 1uL Proteinase K, and 37 DEG C of incubation 10min are transformed into Trans-T1 and cultivate in LB+Spe
37 DEG C of base culture, positive colony is sent be sequenced successfully after, mentioned with the big extraction reagent kit of Plasmid Maxi Kit (Omega company) plasmid
Take plasmid (plasmid concentration requirement > 1ug/uL).
3. Biolistic mediated transformation
Experiment equipment requires sterile: according to equipment property difference or combining using autoclave sterilization, ultraviolet irradiation degerming
It is sterilized with 70% ethyl alcohol.
Each plasmid does 5 biology and repeats, that is, makes a call to 5 disk cells, every 2 rifle of disk, totally 10 rifle.PK7 empty carrier will be converted
Suspension cell is used as control.By 20ug plasmid, 5000ug bronze, the CaCl of 100uL 2.5M2, the spermidine of 40uL 0.1M is mixed
It closes, shakes 2-3min, about 2s is centrifuged after static 1min, abandon supernatant;70% ethyl alcohol of 140uL is added, supernatant is abandoned in centrifugation after flicking;
140uL100% ethyl alcohol is added, supernatant is abandoned in centrifugation after flicking;100uL100% ethyl alcohol is added, after flicking, shakes 2-3s in low speed,
It is placed in ice.
Carrier film after disinfection is placed in iron support, the carrier bronze premixed liquid of the above-mentioned preparation of 10uL is added in each iron support,
Iron support is stopped net, can split film and thunder god vine suspending cell is individually positioned in the phase of particle gun equipment by particle gun working specification
It answers on position, carries out via Particle Bombardment Transformation carrier.Every disk cell makes two rifles.
4. screening and culturing and gene expression analysis
By the complete cell of via Particle Bombardment Transformation, 25 DEG C, dark culture 2d, being transferred to MS screening and culturing medium is MS+Kan culture medium, is resisted
Raw element final concentration Kan is 100mg/ml.After the completion of 20d screening, by the cell subculture after screening in the culture medium of new MS+Kan
In continue to cultivate 20d, be transferred in the fluid nutrient medium of MS+Kan, 25 DEG C, after 120rpm cultivated for 3 generations, take a part of thin later
For extracting RNA after born of the same parents' liquid nitrogen flash freezer, after remaining cell vacuum freeze drying, 0.2g methanol 1ml ultrasound 2h is taken to extract product,
UPLC analyzes product result.
Cell after liquid nitrogen flash freezer crushes under liquid nitrogen environment, is extracted with RNA extracts kit (Promega company) total
RNA, with FastQuant RT Kit kit (Tiangeng) reverse transcription at cDNA, using tripterygium wilfordii EF1 α gene as internal reference.Using
ABI Prism 7300Sequence Detection System (Applied Biosystems, USA) and KAPA SYBR
It is quantitative that FAST Universal 2X qPCR Master Mix (Kapa Biosystems, USA) kit carries out Real-time
PCR.Real time fluorescent quantitative reaction system: 2 × Fast qPCR Master Mix 10uL, positive anti-primer (10mmolL-1) are each
0.4uL, cDNA1uL, 50 × Rox High 0.4uL, PCR-grade water 7.8uL.Reaction condition are as follows: 95 DEG C of 3min, 95
DEG C 3s, 60 DEG C of 30s, 45 circulations: 65~95 DEG C are done solubility curve analysis.After reaction to fluorescent value amplification curve and melting
Curve is analyzed.Biology repeats 5, and technology is repeated 3 times, using 2-△△CT method analyzes result.
As a result see Fig. 5.The suspension cell comparison for being transferred to the interference carrier of the segment containing Twosc3 is transferred to unloaded suspension cell
Twosc3 gene expression amount is remarkably decreased, and (11.73ug/g has dropped than zero load for corresponding trypterygine cellulose content significant decrease
77%).The interference of Twosc3 can lower the synthesis of Celastrol as the result is shown, show that the generation with Celastrol is significant
It is related.
Above description is not limitation of the present invention, and the present invention is also not limited to the example above.The art it is common
Within the essential scope of the present invention, the variations, modifications, additions or substitutions made also should belong to protection of the invention to technical staff
Range, protection scope of the present invention are subject to claims.
Sequence table
<110>Capital University of Medical Sciences
<120>triterpenoids synthase TwOSC3 and its encoding gene and application
<130>in background technique
<141> 2018-08-08
<160> 26
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2475
<212> DNA
<213> Abracris flavolineata
<400> 1
aaacacaaga gattgatata agctctcttg tcttagttcc tcatcatatc atcaagttct 60
tggaggcttc aacctctcat ccttgatagg cttcctctct ggagtgaaga aatcatgtgg 120
aagataaaga tagctgaacg tgggaactgc ccctactccg agtacttgta cactacaaat 180
gactttgttg gtaggcagat atgggagttt gaccctaatg caggcacccc tgaagagctc 240
gctgaggtcg aagaggctcg caagaaattc accgagaacc gccatgaagt caagcctgct 300
tccgacctac tttggatgca gcagtttctg aggcagaaga acttcaagca aacaattcct 360
ccgttgagaa ttggggagaa agaacaagtt acatatgaag atgtcacaac tgctttgaag 420
agagcttcct ctttcttgtc agccttgcaa gccagtgatg gtcactggcc agcagaaaat 480
gctggagtct tgtttttcct tcctccattt atcttttgcc tatacatcac tggacatctc 540
aattcgatta tcacttcgga acatcgtaaa gaaatcctac gtttcatata caaccaccag 600
aatgaagatg ggggttgggg aatacacata gagggacaca gctcaatgtt taccacaaca 660
ttcagctatg tgtgcatgag aatacttgga gtaggaccag atgaaagtgc ttgtgctaga 720
gcaagaaagt ggattcttga tcatggtggc atcacttaca tggcttcctg gggaaagacc 780
tggctttcga tacttggtat atttgattgg tatggatgca acccaatgcc cccagagttc 840
tggattcttc cttcttatct ccctatacat ccagcgaaaa tgtggtgcta ttgccggatg 900
gtttacatgc caatgtcata tctatatggg aaaagatttg ttggtcctat cacacctctc 960
attttacaat tgagagagga gctccacact cagccctacc atgaaattca atggagacaa 1020
atgcgccatc gatgcggaaa ggaggatcta tactatcccc acagtctaat ccagaatttc 1080
ctctgggacg gtctttatgt ggcttctgaa cctcttttga ctcgctggcc ttttagcaag 1140
ataagagaga aggctcttga aaaagcaatg gaacacattc actacgaaga cgaaaatagt 1200
cgatacatca ccattggctg tgttgaaaag gcattgtgta tgctttgttg ctgggttgaa 1260
gaccccaatg gagactattt caagaagcat cttgcaagga taccagatta cttatgggtt 1320
gcagaggatg gtatgaaagt ggtgagtttt ggcagccaac tgtgggatgc tacctttggc 1380
tttcaagctc tggttgctag caatctaaca aatgaagtcg ctccaactct cgtcaaagca 1440
tacgacttcg taaagaaatg ccaggtccgg aataatccct ctggtgactt tgagaaaatg 1500
tttcgccaca tttcaaaagg atcatggact ttctccgatc aagatcatgg atggcaactt 1560
tctgattgca ctgctgaagc attaaagtgt tgcttgctag cagcaaccat gcccgaagaa 1620
cttgttggag agaaattaga tcctcaatgg atatttgagt ctgtaaacat catactttcc 1680
ctccaagagc ctaaaaccgg cggtttagct ggctgggaac cagtaagagc tggacaatgg 1740
atggagatgc tcaaccctat ggagtttctc gagaatattg tgattgaaca tacatatgtc 1800
gagtgtactg gatcttccat cattgctttc attacactca agaagttatt cccaggtcat 1860
aggaccaaag acattgacaa tttcattgta aacggtataa gatatctcga ggacgtgcag 1920
tatcctgatg gctcgtggta tggaaactgg ggtatttgct tcatctatag taccatgttt 1980
gcacttggag ggctagcagc agctggtagg acttacgaaa attgtcccgc tgtgcgcaga 2040
ggtgttgatt ttctacttat taatcagagt gatgatggtg gatggggaga aagctatctt 2100
tcttccccaa gaaagatata tacacctctt gaaggaagaa gatcaaatgt ggtacaaact 2160
gcatgggcta tgctagggct gctctatgct ggccaggttg agagagatcc aactcctctt 2220
caccgcggtg cgaagatact aatcaattac caaatggaag agggaggtta cccccagcag 2280
gaaatcactg gagttttcaa aatgaattgc atgttacact atccaatata taggaatgcc 2340
ttcccaatat gggcgctcgg agagtatcga aatcgtgtta agttgccttc aaaggaaatt 2400
aaatagcaat gaaactaaat tccgtgtaaa aagacgtgaa tgagaataat gtacacaagt 2460
gtccgctaaa tcgaa 2475
<210> 2
<211> 763
<212> PRT
<213> Abracris flavolineata
<400> 2
Met Trp Lys Ile Lys Ile Ala Glu Arg Gly Asn Cys Pro Tyr Ser Glu
1 5 10 15
Tyr Leu Tyr Thr Thr Asn Asp Phe Val Gly Arg Gln Ile Trp Glu Phe
20 25 30
Asp Pro Asn Ala Gly Thr Pro Glu Glu Leu Ala Glu Val Glu Glu Ala
35 40 45
Arg Lys Lys Phe Thr Glu Asn Arg His Glu Val Lys Pro Ala Ser Asp
50 55 60
Leu Leu Trp Met Gln Gln Phe Leu Arg Gln Lys Asn Phe Lys Gln Thr
65 70 75 80
Ile Pro Pro Leu Arg Ile Gly Glu Lys Glu Gln Val Thr Tyr Glu Asp
85 90 95
Val Thr Thr Ala Leu Lys Arg Ala Ser Ser Phe Leu Ser Ala Leu Gln
100 105 110
Ala Ser Asp Gly His Trp Pro Ala Glu Asn Ala Gly Val Leu Phe Phe
115 120 125
Leu Pro Pro Phe Ile Phe Cys Leu Tyr Ile Thr Gly His Leu Asn Ser
130 135 140
Ile Ile Thr Ser Glu His Arg Lys Glu Ile Leu Arg Phe Ile Tyr Asn
145 150 155 160
His Gln Asn Glu Asp Gly Gly Trp Gly Ile His Ile Glu Gly His Ser
165 170 175
Ser Met Phe Thr Thr Thr Phe Ser Tyr Val Cys Met Arg Ile Leu Gly
180 185 190
Val Gly Pro Asp Glu Ser Ala Cys Ala Arg Ala Arg Lys Trp Ile Leu
195 200 205
Asp His Gly Gly Ile Thr Tyr Met Ala Ser Trp Gly Lys Thr Trp Leu
210 215 220
Ser Ile Leu Gly Ile Phe Asp Trp Tyr Gly Cys Asn Pro Met Pro Pro
225 230 235 240
Glu Phe Trp Ile Leu Pro Ser Tyr Leu Pro Ile His Pro Ala Lys Met
245 250 255
Trp Cys Tyr Cys Arg Met Val Tyr Met Pro Met Ser Tyr Leu Tyr Gly
260 265 270
Lys Arg Phe Val Gly Pro Ile Thr Pro Leu Ile Leu Gln Leu Arg Glu
275 280 285
Glu Leu His Thr Gln Pro Tyr His Glu Ile Gln Trp Arg Gln Met Arg
290 295 300
His Arg Cys Gly Lys Glu Asp Leu Tyr Tyr Pro His Ser Leu Ile Gln
305 310 315 320
Asn Phe Leu Trp Asp Gly Leu Tyr Val Ala Ser Glu Pro Leu Leu Thr
325 330 335
Arg Trp Pro Phe Ser Lys Ile Arg Glu Lys Ala Leu Glu Lys Ala Met
340 345 350
Glu His Ile His Tyr Glu Asp Glu Asn Ser Arg Tyr Ile Thr Ile Gly
355 360 365
Cys Val Glu Lys Ala Leu Cys Met Leu Cys Cys Trp Val Glu Asp Pro
370 375 380
Asn Gly Asp Tyr Phe Lys Lys His Leu Ala Arg Ile Pro Asp Tyr Leu
385 390 395 400
Trp Val Ala Glu Asp Gly Met Lys Val Val Ser Phe Gly Ser Gln Leu
405 410 415
Trp Asp Ala Thr Phe Gly Phe Gln Ala Leu Val Ala Ser Asn Leu Thr
420 425 430
Asn Glu Val Ala Pro Thr Leu Val Lys Ala Tyr Asp Phe Val Lys Lys
435 440 445
Cys Gln Val Arg Asn Asn Pro Ser Gly Asp Phe Glu Lys Met Phe Arg
450 455 460
His Ile Ser Lys Gly Ser Trp Thr Phe Ser Asp Gln Asp His Gly Trp
465 470 475 480
Gln Leu Ser Asp Cys Thr Ala Glu Ala Leu Lys Cys Cys Leu Leu Ala
485 490 495
Ala Thr Met Pro Glu Glu Leu Val Gly Glu Lys Leu Asp Pro Gln Trp
500 505 510
Ile Phe Glu Ser Val Asn Ile Ile Leu Ser Leu Gln Glu Pro Lys Thr
515 520 525
Gly Gly Leu Ala Gly Trp Glu Pro Val Arg Ala Gly Gln Trp Met Glu
530 535 540
Met Leu Asn Pro Met Glu Phe Leu Glu Asn Ile Val Ile Glu His Thr
545 550 555 560
Tyr Val Glu Cys Thr Gly Ser Ser Ile Ile Ala Phe Ile Thr Leu Lys
565 570 575
Lys Leu Phe Pro Gly His Arg Thr Lys Asp Ile Asp Asn Phe Ile Val
580 585 590
Asn Gly Ile Arg Tyr Leu Glu Asp Val Gln Tyr Pro Asp Gly Ser Trp
595 600 605
Tyr Gly Asn Trp Gly Ile Cys Phe Ile Tyr Ser Thr Met Phe Ala Leu
610 615 620
Gly Gly Leu Ala Ala Ala Gly Arg Thr Tyr Glu Asn Cys Pro Ala Val
625 630 635 640
Arg Arg Gly Val Asp Phe Leu Leu Ile Asn Gln Ser Asp Asp Gly Gly
645 650 655
Trp Gly Glu Ser Tyr Leu Ser Ser Pro Arg Lys Ile Tyr Thr Pro Leu
660 665 670
Glu Gly Arg Arg Ser Asn Val Val Gln Thr Ala Trp Ala Met Leu Gly
675 680 685
Leu Leu Tyr Ala Gly Gln Val Glu Arg Asp Pro Thr Pro Leu His Arg
690 695 700
Gly Ala Lys Ile Leu Ile Asn Tyr Gln Met Glu Glu Gly Gly Tyr Pro
705 710 715 720
Gln Gln Glu Ile Thr Gly Val Phe Lys Met Asn Cys Met Leu His Tyr
725 730 735
Pro Ile Tyr Arg Asn Ala Phe Pro Ile Trp Ala Leu Gly Glu Tyr Arg
740 745 750
Asn Arg Val Lys Leu Pro Ser Lys Glu Ile Lys
755 760
<210> 3
<211> 23
<212> DNA
<213> Abracris flavolineata
<400> 3
aaacacaaga gattgatata agc 23
<210> 4
<211> 18
<212> DNA
<213> Abracris flavolineata
<400> 4
ttcgatttag cggacact 18
<210> 5
<211> 20
<212> DNA
<213> Abracris flavolineata
<400> 5
agtatcctga tggctcgtgg 20
<210> 6
<211> 20
<212> DNA
<213> Abracris flavolineata
<400> 6
cccatccacc atcatcactc 20
<210> 7
<211> 23
<212> DNA
<213> Abracris flavolineata
<400> 7
ccaagggtga aagcaaggag agc 23
<210> 8
<211> 26
<212> DNA
<213> Abracris flavolineata
<400> 8
cactggtggt tttgaggctg gtatct 26
<210> 9
<211> 32
<212> DNA
<213> Abracris flavolineata
<400> 9
cggggtacca tgtggaagat aaagatagct ga 32
<210> 10
<211> 31
<212> DNA
<213> Abracris flavolineata
<400> 10
cgcggatccc tatttaattt cctttgaagg c 31
<210> 11
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 11
caagatcatg gatggcaaat ttctgattgc 30
<210> 12
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 12
tttgccatcc atgatcttga tcggagaaag 30
<210> 13
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 13
caagatcatg gatggcaagt ttctgattgc 30
<210> 14
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 14
cttgccatcc atgatcttga tcggagaaag 30
<210> 15
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 15
caagatcatg gatggcaatt ttctgattgc 30
<210> 16
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 16
attgccatcc atgatcttga tcggagaaag 30
<210> 17
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 17
caagatcatg gatggcaacc ttctgattgc 30
<210> 18
<211> 31
<212> DNA
<213> Abracris flavolineata
<400> 18
ggttgccatc catgatcttg atcggagaaa g 31
<210> 19
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 19
caagatcatg gatggcaacg ttctgattgc 30
<210> 20
<211> 31
<212> DNA
<213> Abracris flavolineata
<400> 20
cgttgccatc catgatcttg atcggagaaa g 31
<210> 21
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 21
caagatcatg gatggcaagc ttctgattgc 30
<210> 22
<211> 31
<212> DNA
<213> Abracris flavolineata
<400> 22
gcttgccatc catgatcttg atcggagaaa g 31
<210> 23
<211> 30
<212> DNA
<213> Abracris flavolineata
<400> 23
caagatcatg gatggcaatc ttctgattgc 30
<210> 24
<211> 31
<212> DNA
<213> Abracris flavolineata
<400> 24
gattgccatc catgatcttg atcggagaaa g 31
<210> 25
<211> 25
<212> DNA
<213> Abracris flavolineata
<400> 25
caccgcactg ctgaagcatt aaagt 25
<210> 26
<211> 19
<212> DNA
<213> Abracris flavolineata
<400> 26
cataccacga gccatcagg 19
Claims (8)
1. isolated albumen, the albumen are
(1) amino acid sequence shown in SEQ ID NO:2;Or
(2) peptide after the 482nd Leu of amino acid sequence shown in SEQ ID NO:2 is mutated, it is described to sport 482 Leu
Sport Ile, Ser or Val.
2. encoding the polynucleotides of albumen described in claim 1.
3. polynucleotides according to claim 2, the polynucleotides are core shown in SEQ ID NO:1 115-2406
Thuja acid molecule.
4. expression vector, it includes polynucleotides described in promoter, Claims 2 or 3 and transcription terminators, wherein the starting
It is sub to be operably connected with the polynucleotides, and the polynucleotides are operably connected with the transcription terminator.
5. recombinant host cell, it includes expression vector described in polynucleotides described in Claims 2 or 3 or claim 4, institutes
It states cell to be selected from: bacterium or yeast cells.
6. polynucleotides described in albumen or Claims 2 or 3 described in claim 1 are adjusting and are producing plant triterpene class chemical combination
Application in object.
7. application as claimed in claim 6, wherein the triterpene compound is suberone, beta-amyrin or Celastrol.
8. application of the polynucleotides described in albumen or Claims 2 or 3 described in claim 1 in tripterygium wilfordii plant breeding.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810895867.6A CN108866029B (en) | 2018-08-08 | 2018-08-08 | Triterpenoids synthase TwOSC3 and its encoding gene and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810895867.6A CN108866029B (en) | 2018-08-08 | 2018-08-08 | Triterpenoids synthase TwOSC3 and its encoding gene and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108866029A CN108866029A (en) | 2018-11-23 |
CN108866029B true CN108866029B (en) | 2019-06-04 |
Family
ID=64317230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810895867.6A Active CN108866029B (en) | 2018-08-08 | 2018-08-08 | Triterpenoids synthase TwOSC3 and its encoding gene and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108866029B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112779231B (en) * | 2019-11-07 | 2022-07-05 | 中国中医科学院中药研究所 | Borneol camphor and borneol dehydrogenase CcBDH3 as well as encoding gene and application thereof |
CN112779242B (en) * | 2019-11-07 | 2023-03-28 | 四川弘合生物科技有限公司 | Plum tree monoterpene synthase CbTPS1 and related biological material and application thereof |
CN110747178B (en) * | 2019-11-08 | 2021-05-07 | 首都医科大学 | Application of tripterygium wilfordii cytochrome p450 oxidase in preparation of abietane-type diterpene compound |
CN111647589A (en) * | 2020-06-08 | 2020-09-11 | 上海大学 | Euphorbia dienol synthase and coding gene and application thereof |
CN116615554A (en) | 2020-08-27 | 2023-08-18 | 哥本哈根大学 | Preparation of oxygen-containing diterpene compounds |
CN114410495B (en) * | 2022-01-06 | 2023-12-08 | 首都医科大学 | Recombinant yeast engineering bacteria for high-yield wood-bolt ketone |
CN114410726B (en) * | 2022-01-19 | 2024-03-26 | 首都医科大学附属北京世纪坛医院 | C-14 and C-12 hydroxylases of tricyclic diterpenoids |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496804A (en) * | 2008-01-31 | 2009-08-05 | 烟台靶点药物研究有限公司 | Composition containing tripterine, preparation method and use |
CN104212787A (en) * | 2014-09-01 | 2014-12-17 | 黄璐琦 | Panax japonicas beta-amyrin synthase gene and application thereof |
CN106520745A (en) * | 2016-11-25 | 2017-03-22 | 首都医科大学 | Tripterygium wilfordii diterpene synthase TwGES1 and encoding gene and application thereof |
CN106543289A (en) * | 2016-11-25 | 2017-03-29 | 首都医科大学 | Radix Tripterygii Wilfordii sesquiterpene synthase TwNES and its encoding gene and application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11149282B2 (en) * | 2011-10-03 | 2021-10-19 | University Of Kentucky Research Foundation | Systems and methods for the production of linear and branched-chain hydrocarbons |
-
2018
- 2018-08-08 CN CN201810895867.6A patent/CN108866029B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496804A (en) * | 2008-01-31 | 2009-08-05 | 烟台靶点药物研究有限公司 | Composition containing tripterine, preparation method and use |
CN104212787A (en) * | 2014-09-01 | 2014-12-17 | 黄璐琦 | Panax japonicas beta-amyrin synthase gene and application thereof |
CN106520745A (en) * | 2016-11-25 | 2017-03-22 | 首都医科大学 | Tripterygium wilfordii diterpene synthase TwGES1 and encoding gene and application thereof |
CN106543289A (en) * | 2016-11-25 | 2017-03-29 | 首都医科大学 | Radix Tripterygii Wilfordii sesquiterpene synthase TwNES and its encoding gene and application |
Non-Patent Citations (2)
Title |
---|
Accession NO:ADK12003,beta-amyrin synthase [Aralia elata];Wu,Y.等;《GenBank》;20120822;Descriptions,Alignments,DBSOURCE和FEATURES |
Accession NO:APG38073,Friedelin synthase [Monteverdia ilicifolia];Souza-Moreira,T.M.等;《GenBank》;20161207;Descriptions,Alignments,DBSOURCE和FEATURES |
Also Published As
Publication number | Publication date |
---|---|
CN108866029A (en) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108866029B (en) | Triterpenoids synthase TwOSC3 and its encoding gene and application | |
CN108866030B (en) | Triterpenoids synthase TwOSC1 and its encoding gene and application | |
CN103667370B (en) | The polynucleotide of coding isoprenoid modifying enzymes and its using method | |
PT2304040T (en) | Production of alkenes by enzymatic decarboxylation of 3-hydroxyalkanoic acids | |
CN107567492A (en) | UDP glycosyl transferases | |
CN108060092A (en) | A kind of recombinant bacterium and application thereof | |
CN110438099A (en) | The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1 | |
CN101928717A (en) | Salvia miltrorrhiza squalene synthase (SmSQS) gene and encoding protein and application thereof | |
CN111032875B (en) | Use of type III polyketide synthases as phloroglucinol synthases | |
CN109957555A (en) | A kind of glycosyl transferase mutant and its application in catalysis Gastrodin biosynthesis | |
Matveeva et al. | Opine biosynthesis in naturally transgenic plants: Genes and products | |
CN115786149A (en) | Saccharomyces cerevisiae strain for producing breast milk lipid substitute and application thereof | |
CN109750048A (en) | Apple saccharide transporter gene M dERDL6 and its application | |
CN103243083B (en) | Novel sesquiterpene synthetase and application thereof | |
CN109401985A (en) | The Δ Tlrgt2 trichoderma engineering bacteria and its construction method of one plant height production peptaibols antibacterial peptide and application | |
CN113265381B (en) | Separated CYP450 protein, coding gene thereof and application thereof | |
CN108330111A (en) | Cytochrome P450 mutain and its application | |
CN109136119B (en) | Microorganisms and uses thereof | |
CN117866933A (en) | Oxidation squalene cyclase NiOSC5, encoding gene and application thereof | |
CN101928715A (en) | Salviamiltiorrhizabge-cytochrome P450 (SmP450) gene as well as coded protein and application thereof | |
CN111363006B (en) | Ganoderma lucidum mycelium antihypertensive peptide and preparation method thereof | |
CN108998428B (en) | Paris polyphylla cholesterine C22 hydroxylase and its encoding gene and application | |
CN101942422B (en) | Genes of D-lactic dehydrogenase from serratia marcescens and research of cloning and expressing recombinant strains and recombinant enzymes | |
CN115305254B (en) | Terpenoid chassis microorganism and engineering bacterium as well as construction method and application thereof | |
CN109136120B (en) | Microorganisms and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |